title: Contribution of the NQO1 and GSTT1 polymorphisms to lung adenocarcinoma susceptibility.
abstract: Lung adenocarcinoma has replaced squamous cell lung carcinoma as the most frequent histological subtype in lung cancers. However, genetic factors that affect cancer susceptibility are much less understood in adenocarcinoma than in squamous cell carcinoma. In this study, polymorphisms in five genes involved in the metabolism of carcinogens or in the repair of damaged DNA in lung cells, NQO1-Pro187Ser, GSTT1-positive/null, GSTM1-positive/null, CYP1A1-Ile462Val, and OGG1-Ser326Cys, were examined for association with lung adenocarcinoma risk in a case-control study of 198 patients and 152 control subjects. The NQO1 and GSTT1 polymorphisms were associated with lung adenocarcinoma risk with adjusted odds ratio of 2.15 for the NQO1-Pro/Pro genotype versus the Ser/Ser genotype and adjusted odds ratio of 1.61 for the GSTT1-null genotype versus the positive genotype, respectively. Furthermore, individuals with the combined genotype of NQO1-Pro/Pro and GSTT1-null showed greater risk compared with those of NQO1-Ser/Ser and GSTT1-positive. In contrast, significant association was not observed for the GSTM1, CYP1A1, and OGG1 polymorphisms with lung adenocarcinoma risk, although several studies have shown their implication in the risk for squamous cell lung carcinoma. The result indicates that the NQO1-Pro/Pro and GSTT1-null genotypes are risk factors for lung adenocarcinoma development, and that the genetic factors for susceptibility to adenocarcinoma are different from those to squamous cell carcinoma. The enhanced risk of the NQO1-Pro/Pro genotype combined with the GSTT1-null genotype was more evident in smokers than in nonsmokers. Therefore, carcinogens in tobacco smoke, which are activated by NQO1 and detoxified by GSTT1, could have a role in lung adenocarcinoma development.
authors.affiliation: Biology Division, National Cancer Center Research Institute, Tokyo, Japan.
authors.forename: Noriaki
authors.initials: N
authors.lastname: Sunaga
authors.forename: Takashi
authors.initials: T
authors.lastname: Kohno
authors.forename: Noriko
authors.initials: N
authors.lastname: Yanagitani
authors.forename: Haruhiko
authors.initials: H
authors.lastname: Sugimura
authors.forename: Hideo
authors.initials: H
authors.lastname: Kunitoh
authors.forename: Tomohide
authors.initials: T
authors.lastname: Tamura
authors.forename: Yoshikazu
authors.initials: Y
authors.lastname: Takei
authors.forename: Satoshi
authors.initials: S
authors.lastname: Tsuchiya
authors.forename: Ryusei
authors.initials: R
authors.lastname: Saito
authors.forename: Jun
authors.initials: J
authors.lastname: Yokota
mesh_terms: D000230:Adenocarcinoma / Q000209:etiology* / Q000235:genetics*; D000328:Adult; D002273:Carcinogens / Q000378:metabolism; D002289:Carcinoma, Non-Small-Cell Lung / Q000209:etiology* / Q000235:genetics*; D016022:Case-Control Studies; D004249:DNA Damage; D005260:Female; D020022:Genetic Predisposition to Disease; D005838:Genotype; D005982:Glutathione Transferase / Q000235:genetics* / Q000494:pharmacology; D006801:Humans; D008175:Lung Neoplasms / Q000209:etiology* / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D016017:Odds Ratio; D011110:Polymorphism, Genetic; D011808:Quinone Reductases / Q000235:genetics* / Q000494:pharmacology; D012307:Risk Factors; D012907:Smoking / Q000009:adverse effects
chemical_list: D002273:Carcinogens; C041831:NADH dehydrogenase (quinone); D011808:Quinone Reductases; C413545:glutathione S-transferase T1; D005982:Glutathione Transferase